Summary
Pfizer has been active since 1954 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show a net result of €3.7m. Equity remains stable across the filed fiscal years (±2.2% per year). Its net result ranks better than 94% of 4914 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 29 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
History
On 1 February 1954, Pfizer was incorporated.1 In 2005 the registered office moved to Bruxelles.2 The capital was increased 3 times between 2010 and 2020, most recently to EUR 40 million.345 Wyeth Pharmaceuticals and PF OFG Belgium were merged into the company between 2010 and 2019.34 Of the 3 current board members, Laurence Einsweiler has served longest, since 2013.6 Revenue went from EUR 221 million in 2019 to EUR 358 million in 2025 and headcount from 319 to 297 full-time equivalents.7
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Click a name to add, emphasise or remove a line.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €543.0m | €632.9m | €413.6m | €392.6m | €414.1m | ▲ 5.5% |
| Turnover70 | €469.5m | €548.2m | €349.4m | €336.5m | €358.3m | ▲ 6.5% |
| Other operating income74 | €71.9m | €84.7m | €64.2m | €56.1m | €55.8m | ▼ 0.6% |
| Non-recurring operating income76A | €1.6m | - | - | - | - | - |
| Operating charges60/66A | €515.9m | €603.1m | €392.9m | €356.3m | €399.0m | ▲ 12.0% |
| Goods for resale, raw materials and consumables60 | €401.7m | €467.8m | €275.1m | €222.0m | €274.6m | ▲ 23.7% |
| Change in stocks: decrease (increase)609 | €3.8m | -€40.0m | -€42.2m | -€23.7m | €17.3m | ▲ 173% |
| Services and other goods61 | €44.4m | €47.0m | €42.9m | €36.9m | €34.7m | ▼ 6.0% |
| Remuneration, social security and pensions62 | €56.5m | €66.1m | €64.9m | €76.4m | €53.9m | ▼ 29.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1.2m | €1.1m | €983,318 | €1.0m | €1.0m | ▼ 3.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | -€1.8m | -€302,541 | €2.9m | €5.8m | -€4.4m | ▼ 176% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €1.1m | €7.8m | -€7.0m | -€2.3m | €18.4m | ▲ 917% |
| Other operating charges640/8 | €12.8m | €13.5m | €13.2m | €16.5m | €20.8m | ▲ 26.1% |
| Operating profit (loss)9901 | €27.1m | €29.8m | €20.7m | €36.2m | €15.1m | ▼ 58.2% |
| Recurring financial income75 | €219,910 | €798,519 | €1.2m | €1.3m | €1.3m | ▼ 1.7% |
| Income from current assets751 | €13,572 | €136,816 | €710,096 | €1.1m | €744,694 | ▼ 31.0% |
| Other financial income752/9 | €206,338 | €661,703 | €442,999 | €252,313 | €564,226 | ▲ 124% |
| Financial charges65/66B | €303,062 | €1.0m | €3.8m | €4.9m | €3.7m | ▼ 25.4% |
| Recurring financial charges65 | €303,062 | €1.0m | €3.8m | €4.9m | €3.7m | ▼ 25.4% |
| Debt charges650 | €126,527 | €315,003 | €3.3m | €4.3m | €2.8m | ▼ 34.3% |
| Other financial charges652/9 | €176,535 | €694,578 | €548,100 | €563,236 | €808,000 | ▲ 43.5% |
| Profit (loss) for the period before taxes9903 | €27.0m | €29.6m | €18.0m | €32.6m | €12.8m | ▼ 60.8% |
| Income taxes67/77 | €7.5m | €8.0m | €5.1m | €9.5m | €9.1m | ▼ 3.5% |
| Taxes670/3 | €7.5m | €8.1m | €5.1m | €9.5m | €9.1m | ▼ 3.5% |
| Tax adjustments and reversals of tax provisions77 | €9,366 | €114,849 | - | - | - | - |
| Profit (loss) for the period9904 | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| Profit (loss) for the period to be appropriated9905 | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €254.7m | €285.3m | €383.4m | €474.6m | €377.4m | ▼ 20.5% |
| Fixed assets21/28 | €10.1m | €11.2m | €11.1m | €10.1m | €11.4m | ▲ 12.9% |
| Tangible fixed assets22/27 | €5.3m | €6.4m | €6.0m | €5.1m | €6.4m | ▲ 25.5% |
| Plant, machinery and equipment23 | €766,822 | €731,499 | €698,318 | €524,967 | €402,022 | ▼ 23.4% |
| Furniture and vehicles24 | €319,344 | €565,140 | €630,594 | €924,462 | €695,213 | ▼ 24.8% |
| Other tangible fixed assets26 | €4.1m | €4.3m | €4.1m | €3.5m | €3.0m | ▼ 15.6% |
| Assets under construction and advance payments27 | €77,279 | €782,903 | €620,634 | €87,279 | €2.3m | ▲ 2,518% |
| Financial fixed assets28 | €4.8m | €4.8m | €5.1m | €5.1m | €5.1m | ▲ 0.3% |
| Affiliated companies280/1 | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | = |
| Participating interests280 | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | = |
| Other financial fixed assets284/8 | €548,694 | €570,504 | €829,227 | €808,456 | €822,706 | ▲ 1.8% |
| Amounts receivable and cash guarantees285/8 | €548,694 | €570,504 | €829,227 | €808,456 | €822,706 | ▲ 1.8% |
| Current assets29/58 | €244.6m | €274.0m | €372.3m | €464.5m | €365.9m | ▼ 21.2% |
| Stocks and contracts in progress3 | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Stocks30/36 | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Goods purchased for resale34 | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Amounts receivable within one year40/41 | €111.3m | €142.4m | €179.8m | €165.6m | €166.0m | ▲ 0.2% |
| Trade receivables40 | €109.6m | €136.3m | €171.0m | €161.0m | €123.7m | ▼ 23.2% |
| Other amounts receivable41 | €1.7m | €6.1m | €8.8m | €4.6m | €42.3m | ▲ 823% |
| Current investments50/53 | - | - | €63,697 | €87.1m | €18,311 | ▼ 100.0% |
| Other investments51/53 | - | - | €63,697 | €87.1m | €18,311 | ▼ 100.0% |
| Cash at bank and in hand54/58 | €40.7m | €724,690 | €21.9m | €21.3m | €23.9m | ▲ 12.1% |
| Deferred charges and accrued income490/1 | €2.2m | €201,752 | €426,728 | €2.5m | €909,253 | ▼ 63.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €254.7m | €285.3m | €383.4m | €474.6m | €377.4m | ▼ 20.5% |
| Equity10/15 | €118.8m | €90.4m | - | - | - | - |
| Contributions10/11 | €40.8m | €40.8m | €40.8m | €40.8m | €40.8m | = |
| Capital10 | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | = |
| Issued capital100 | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | = |
| Outside capital11 | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | = |
| Share premium1100/10 | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | = |
| Reserves13 | €8.0m | €8.0m | €8.0m | €8.0m | €8.0m | = |
| Non-distributable reserves130/1 | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Legal reserve130 | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Other1319 | €23,251 | €23,251 | €23,251 | €23,251 | €23,251 | = |
| Tax-exempt reserves132 | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Distributable reserves133 | €14,909 | €14,909 | €14,909 | €14,909 | €14,909 | = |
| Profit (loss) carried forward14 | €70.0m | €41.6m | €54.5m | €77.7m | €81.4m | ▲ 4.7% |
| Provisions and deferred taxes16 | €3.6m | €11.4m | - | - | - | - |
| Provisions for liabilities and charges160/5 | €3.6m | €11.4m | €4.4m | €2.1m | €20.5m | ▲ 876% |
| Pensions and similar obligations160 | - | €3.7m | - | - | - | - |
| Other liabilities and charges164/5 | €3.6m | €7.6m | €4.4m | €2.1m | €20.5m | ▲ 876% |
| Amounts payable17/49 | €132.2m | €183.5m | €275.7m | €346.0m | €226.6m | ▼ 34.5% |
| Amounts payable within one year42/48 | €130.1m | €182.6m | €249.2m | €338.4m | €224.7m | ▼ 33.6% |
| Financial debts43 | - | €81.3m | €146.6m | €24,443 | €162.9m | ▲ 666,233% |
| Credit institutions430/8 | - | - | - | €24,443 | €827,285 | ▲ 3,285% |
| Other loans439 | - | €81.3m | €146.6m | - | €162.0m | - |
| Trade debts44 | €66.4m | €26.4m | €5.9m | €75.9m | €34.0m | ▼ 55.1% |
| Suppliers440/4 | €66.4m | €26.4m | €5.9m | €75.9m | €34.0m | ▼ 55.1% |
| Taxes, remuneration and social security45 | €63.7m | €75.0m | €76.4m | €255.6m | €23.3m | ▼ 90.9% |
| Taxes450/3 | €46.9m | €52.4m | €60.9m | €237.6m | €7.0m | ▼ 97.1% |
| Remuneration and social security454/9 | €16.8m | €22.5m | €15.6m | €18.0m | €16.3m | ▼ 9.3% |
| Other amounts payable47/48 | €22,075 | - | €20.3m | €6.9m | €4.5m | ▼ 35.0% |
| Accrued charges and deferred income492/3 | €2.1m | €828,249 | €26.5m | €7.7m | €1.9m | ▼ 74.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| + Depreciation and write-downs630 | €1.2m | €1.1m | €983,318 | €1.0m | €1.0m | ▼ 3.4% |
| Operating cash flow (approximation) | €20.7m | €22.7m | €13.9m | €24.2m | €4.7m | ▼ 80.7% |
| Investment in fixed assets (approximation) | - | -€2.3m | -€824,629 | -€90,096 | -€2.3m | ▼ 2,470% |
| Change in cash | - | -€40.0m | €21.2m | -€591,241 | €2.6m | ▲ 535% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
04-08
State Gazette act
Resignations: Guy Van den Meersche (director) and Anne De Backer (director)Appointment: Kathleen Commers (director) · Director discharge9 facts ▸
- General meeting, 01-07-2026
- Director resignation, Guy Van den Meersche (director)
- Director resignation, Anne De Backer (director)
- Director discharge, Guy Van den Meersche
- Director discharge, Anne De Backer
- Director appointment, Kathleen Commers (director)
- Board composition, Réginald Decraene (director)
- Board composition, Laurence Einsweiler (director)
- Board composition, Kathleen Commers (director)
19-01
State Gazette act
Resignation: David Lepoittevin (director)Appointment: Réginald Decraene (director) · Director discharge · Mandate compensation8 facts ▸
- General meeting, 20/11/2025
- Board meeting, 24/11/2025
- Director resignation, David Lepoittevin (director)
- Director resignation, David Lepoittevin (managing director)
- Director discharge, David Lepoittevin
- Director appointment, Réginald Decraene (director)
- Mandate compensation, Réginald Decraene
- Director appointment, Réginald Decraene (managing director)
26-06
State Gazette act
Reappointment: Laurence Einsweiler (director)Appointment: KPMG Réviseurs d'Entreprises SRL (statutory auditor) · Mandate compensation4 facts ▸
- General meeting, 21 mai 2025
- Director reappointment, Laurence Einsweiler (director)
- Mandate compensation, Laurence Einsweiler
- Auditor appointment, KPMG Réviseurs d'Entreprises SRL (statutory auditor)
21-03
State Gazette act
Resignation: An Van Gerven (managing director)Appointments: David Lepoittevin (director) and KPMG Bedrijfsrevisoren (statutory auditor) · Permanent representative: Steven Veyt · Director discharge19 facts ▸
- General meeting, 17/02/2025
- Board meeting, 18/02/2025
- Director resignation, An Van Gerven (managing director)
- Director discharge, An Van Gerven
- Director appointment, David Lepoittevin (director)
- Mandate compensation, David Lepoittevin
- Permanent representative, Steven Veyt
- Auditor appointment, KPMG Bedrijfsrevisoren (statutory auditor)
- Director resignation, An Van Gerven (délégation de la gestion journalière)
- Director appointment, David Lepoittevin (managing director)
- Power of attorney, Catherine Pélissier
- Power of attorney, Dimitri Galle
- +7 further facts in this act
24-05
State Gazette act
Resignations & appointmentsOfficer change · Power of attorney · Mandate term15 facts ▸
- Board meeting, 26/04/2023
- Board meeting, 27/04/2023
- Officer change
- Power of attorney, DLA Piper UK LLP
- Power of attorney, Philippe Legrand
- Power of attorney, Véronique Gobiet
- Power of attorney, Micheline Vrancken
- Power of attorney, Nathalie Gonnissen
- Power of attorney, Catherine Pélissier
- Power of attorney, Ana Moreno Morales de Setien
- Power of attorney, Dimitri Galle
- Power of attorney, Machiel De Dauw
- +3 further facts in this act
06-12
State Gazette act
Resignation: Karel van de Sompel (director)Appointment: An Van Gerven (director) · Mandate compensation · Power of attorney8 facts ▸
- General meeting, 03/10/2022
- Director resignation, Karel van de Sompel (director)
- Director appointment, An Van Gerven (director)
- Mandate compensation, An Van Gerven
- Board meeting, 03/10/2022
- Director resignation, Karel van de Sompel (managing director)
- Power of attorney, Karel van de Sompel
- Director appointment, An Van Gerven (managing director)
Show earlier events
19-08
State Gazette act
Appointment: KPMG Réviseurs d'Entreprises SRL (statutory auditor)2 facts ▸
- General meeting, 10/06/2022
- Auditor appointment, KPMG Réviseurs d'Entreprises SRL (statutory auditor)
26-08
State Gazette act
Resignation: Didier Vinel (director)Appointments: Guy Van den Meersche (director) and Anne De Backer (director) · Mandate compensation6 facts ▸
- General meeting, 18/05/2021
- Director resignation, Didier Vinel (director)
- Director appointment, Guy Van den Meersche (director)
- Director appointment, Anne De Backer (director)
- Mandate compensation, Guy Van den Meersche
- Mandate compensation, Anne De Backer
03-08
State Gazette act
Resignation: Didier Vinel (director)Appointments: Guy Van den Meersche (director) and Anne De Backer (director) · Mandate compensation · Mandate acceptance8 facts ▸
- General meeting, 18/05/2021
- Director resignation, Didier Vinel (director)
- Director appointment, Guy Van den Meersche (director)
- Director appointment, Anne De Backer (director)
- Mandate compensation, Guy Van den Meersche
- Mandate compensation, Anne De Backer
- Mandate acceptance, ja
- Mandate acceptance, ja
20-05
State Gazette act
Capital & shares · Statutes amendmentCapital increase · Capital · Net-asset statement6 facts ▸
- General meeting, 30/04/2020
- Capital increase, €10.750.006,46
- Capital, €39.688.620,47
- Statutes amendment
- Net-asset statement, 25/02/2019
- Power of attorney, DLA Piper
11-03
State Gazette act
Capital & sharesCapital2 facts ▸
- General meeting, 21/01/2020
- Capital, €50.000.000
19-02
State Gazette act
MiscellaneousDividend distribution2 facts ▸
- General meeting, 21/01/2020
- Dividend distribution, 50.000.000 EUR
10-07
State Gazette act
MiscellaneousShare transfer1 fact ▸
- Share transfer, Pfizer International Markets B.V.
18-06
State Gazette act
Reappointments: Karel Van De Sompel, Didier Vinel and Laurence EinwellerAppointment: KPMG Réviseurs d'Entreprises (statutory auditor) · Permanent representative: Olivier Declercq · Mandate compensation9 facts ▸
- General meeting, 15/05/2019
- Director reappointment, Karel Van De Sompel (director)
- Director reappointment, Didier Vinel (director)
- Director reappointment, Laurence Einweller (director)
- Mandate compensation, Karel Van De Sompel
- Mandate compensation, Didier Vinel
- Mandate compensation, Laurence Einweller
- Auditor appointment, KPMG Réviseurs d'Entreprises (statutory auditor)
- Permanent representative, Olivier Declercq
03-04
State Gazette act
Resignations & appointmentsPower of attorney5 facts ▸
- Board meeting, 11/03/2019
- Power of attorney, Ann Matton (mandataire)
- Power of attorney, Isabel Vanderriest (mandataire)
- Power of attorney, Annelies Inzé (mandataire)
- Power of attorney, Rembert Van De Sande (mandataire)
19-03
State Gazette act
Capital & shares · RestructuringMerger · Accounting effect · Capital increase8 facts ▸
- General meeting, 22/02/2019
- Merger, 25/02/2019
- Accounting effect, 25/02/2019
- Capital increase, €10.666.355
- Share issue, 66895
- Capital, €39.604.969,01
- Power of attorney, DLA Piper
- Power of attorney, Ernst & Young Réviseurs d'Entreprises
05-03
State Gazette act
Resignations & appointmentsPower of attorney8 facts ▸
- Board meeting, 05/02/2019
- Power of attorney, Catherine Pélissier
- Power of attorney, An Van Gerven
- Power of attorney, Véronique Gobiet
- Power of attorney, Micheline Vrancken
- Power of attorney, Nathalie Gonnissen
- Power of attorney, Catherine Pélissier
- Power of attorney, Ana Moreno De Setien
22-01
State Gazette act
RestructuringMerger · Accounting effect · Share issue10 facts ▸
- Merger, absorption, scission partielle de Pfizer PFE au bénéfice de PF OFG
- Accounting effect, 25/02/2019
- Board meeting, 09/01/2019
- Share issue, actions nominatives ordinaires, sans mention de valeur nominale, 66895
- Mandate compensation, KPMG Réviseurs d'Entreprises BCVBA
- Market value, 56.018.500 EUR
- Market value, 125.000.000 EUR
- Number of shares, 5617015935
- Number of shares, 149271
- Valuation date, 07/01/2019
06-12
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
- Board meeting, 10/11/2017
- Power of attorney, Anne De Backer (hr mos lead)
14-11
State Gazette act
Permanent representatives: Olivier Declercq and Patrick Simons3 facts ▸
- Board meeting, 29/09/2017
- Permanent representative, Olivier Declercq
- Permanent representative, Patrick Simons
28-06
State Gazette act
Resignations & appointmentsPower of attorney2 facts ▸
- Board meeting, 08/06/2017
- Power of attorney, Stéphane Komar
27-06
State Gazette act
Appointment: SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprise (KPMG) (statutory auditor)2 facts ▸
- General meeting, 18/05/2016
- Auditor appointment, SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprise (KPMG) (statutory auditor)
17-02
State Gazette act
Resignations & appointmentsPower of attorney5 facts ▸
- Board meeting, 25/01/2016
- Power of attorney, Jorgen Schaffers
- Power of attorney, Dominique Winand
- Power of attorney, Catherine Pélissier
- Power of attorney, An Van Gerverı
29-12
State Gazette act
RestructuringCapital decrease · Capital · Net-asset statement6 facts ▸
- General meeting, 30/11/2015
- Capital decrease, €16.975.840,99
- Capital, €28.938.614,01
- Net-asset statement, 30/11/2014
- Statutes amendment
- Demerger, 30/11/2015
24-11
State Gazette act
Capital & sharesDividend distribution4 facts ▸
- General meeting, 05/11/2015
- Dividend distribution, dividende intermédiaire
- Dividend distribution, dividende intermédiaire
- Dividend distribution, dividende intermédiaire total
15-10
State Gazette act
Reappointment: Karel Van De Sompel (managing director)2 facts ▸
- Board meeting, 24/09/2015
- Director reappointment, Karel Van De Sompel (managing director)
01-07
State Gazette act
Reappointments: Karel Van De Sompel (director) and Didier Vinel (director)Mandate compensation5 facts ▸
- General meeting, 20/05/2015
- Director reappointment, Karel Van De Sompel (director)
- Mandate compensation, Karel Van De Sompel
- Director reappointment, Didier Vinel (director)
- Mandate compensation, Didier Vinel
30-12
State Gazette act
Capital & shares · Statutes amendment · RestructuringDemerger · Accounting effect · Net-asset statement13 facts ▸
- General meeting, 01/12/2014
- Board meeting, 28/11/2014
- Demerger, GEP Business Scindé (Global Established Pharmaceutical Business)
- Accounting effect, 01/12/2014
- Net-asset statement, 01/12/2014
- Capital decrease, €18.489.777,79
- Capital, €27.424.677,21
- Share issue, parts sociales nominatives ordinaires, 67000000
- Power of attorney, DLA Piper UK LLP
- Statutes amendment
- Exchange ratio, chaque action de Pfizer donnant droit à 448,848068278 parts sociales de Pfizer PFE
- Equity reduction, 40.423.415,93, EUR
- +1 further facts in this act
27-10
State Gazette act
RestructuringDemerger · Accounting effect · Share issue4 facts ▸
- Demerger
- Accounting effect, 01/12/2014
- Share issue, nouvelles parts sociales de Pfizer PFE émises au profit des actionnaires de Pfizer
- Power of attorney, DLA Piper UK LLP
20-06
State Gazette act
Appointment: SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprise (KPMG) (statutory auditor)2 facts ▸
- General meeting, 27/05/2014
- Auditor appointment, SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprise (KPMG) (statutory auditor)
01-04
State Gazette act
Resignations & appointmentsPower of attorney7 facts ▸
- Board meeting, 21/02/2014
- Power of attorney, Alain Bovée
- Power of attorney, Jorgen Schaffers
- Power of attorney, Dominique Winand
- Power of attorney, Catherine Pélissier
- Power of attorney, Jorgen Schaffers
- Power of attorney, Dominique Winand
27-01
State Gazette act
MiscellaneousShare transfer1 fact ▸
- Share transfer, Pfizer International Markets Coöperatief UA
28-11
State Gazette act
Capital & sharesApproval2 facts ▸
- General meeting, 07/11/2013
- Approval, 07/11/2013
26-11
State Gazette act
MiscellaneousShare acquisition1 fact ▸
- Share acquisition, Pfizer International Markets Coöperatief UA becomes sole shareholder, 149.271
06-11
State Gazette act
Capital & sharesShare transfer · Share cancellation · Capital6 facts ▸
- General meeting, 08/10/2013
- Share transfer, AHP Holdings B.V. → Pfizer
- Share cancellation, 29388, imputation des réserves taxées/bénéfices non distribués antérieurement
- Capital
- Statutes amendment
- Power of attorney, Laurence Einsweiler
22-10
State Gazette act
Appointment: SCRL KLYNVELD PEAT MARWICK GOERDELER-Réviseurs d'Entrepríse (KPMG) (statutory auditor)2 facts ▸
- General meeting, 15/05/2013
- Auditor appointment, SCRL KLYNVELD PEAT MARWICK GOERDELER-Réviseurs d'Entrepríse (KPMG) (statutory auditor)
25-09
State Gazette act
Resignation: Erik BROUWER (director)Appointment: Laurence EINSWEILER (director)3 facts ▸
- General meeting, 29/08/2013
- Director resignation, Erik BROUWER (director)
- Director appointment, Laurence EINSWEILER (director)
19-07
State Gazette act
Resignations & appointmentsPower of attorney · Mandate effective date3 facts ▸
- Board meeting
- Power of attorney, Hugues Botman (hr mos region lead belux)
- Mandate effective date, 01/07/2013
16-05
State Gazette act
Appointment: Karel VAN DE SOMPEL (managing director)2 facts ▸
- Board meeting, 25/04/2012
- Director appointment, Karel VAN DE SOMPEL (managing director)
26-04
State Gazette act
Resignation: Kristiaan J. WESTELINCK (managing director and director)Appointment: Didier VINEL (director) · Accounting effect4 facts ▸
- General meeting, 30/03/2012
- Accounting effect, 01/04/2012
- Director resignation, Kristiaan J. WESTELINCK (managing director and director)
- Director appointment, Didier VINEL (director)
03-04
State Gazette act
Resignation: Etienne CATTHOOR (director)Appointment: Karel VAN DE SOMPEL (director) · Accounting effect · Mandate compensation5 facts ▸
- General meeting, 05/03/2012
- Accounting effect, 01/03/2012
- Director resignation, Etienne CATTHOOR (director)
- Director appointment, Karel VAN DE SOMPEL (director)
- Mandate compensation, Karel VAN DE SOMPEL
30-03
State Gazette act
PurposePurpose change2 facts ▸
- General meeting, 29/02/2012
- Purpose change, La Société a également pour objet la fourniture aux professionnels de la santé de conseils et de prestations de services de quelque nature que ce soit dans les…
05-12
State Gazette act
Resignations & appointmentsPower of attorney5 facts ▸
- Board meeting, 18/08/2011
- Power of attorney, Laurence Einsweiler
- Power of attorney, Alain Bovée
- Power of attorney, Jorgen Schaffers
- Power of attorney, Dominique Winand
09-11
State Gazette act
Appointment: Erik BROUWER (director)Mandate compensation3 facts ▸
- General meeting, 27/09/2011
- Director appointment, Erik BROUWER (director)
- Mandate compensation, Erik BROUWER
27-07
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointments · RestructuringMerger · Accounting effect · Capital increase14 facts ▸
- General meeting, 30/06/2010
- Merger
- Accounting effect, 01/12/2009
- Capital increase, €7.138.000
- Share issue, nouvelles actions sans valeur nominale, entièrement libérées
- Share transfer, Pfizer → AHP Holdings B.V.
- Share transfer, Pfizer → A.H. Robins International Company
- Capital, €45.914.455
- Statutes amendment
- Power of attorney, Nicolas Joseph Thomas BAYERS
- Power of attorney, Nicolas Joseph Thomas BAYERS
- Exchange ratio, 1 nouvelle action de la Société Absorbante contre remise de 10,14 actions de la Société Absorbée
- +2 further facts in this act
27-07
State Gazette act
Resignations & appointmentsPower of attorney3 facts ▸
- Board meeting, 01/06/2010
- Power of attorney, Eva Lauwers
- Power of attorney, Anne De Backer (hr mos lead)
23-07
State Gazette act
Appointment: Arnaud Conan (daily management delegate)Power of attorney3 facts ▸
- Board meeting, 06/07/2010
- Power of attorney, Eva Lauwers
- Director appointment, Arnaud Conan (daily management delegate)
16-06
State Gazette act
Appointment: SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprises (KPMG) (statutory auditor)2 facts ▸
- General meeting, 19/05/2010
- Auditor appointment, SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprises (KPMG) (statutory auditor)
27-05
State Gazette act
RestructuringMerger1 fact ▸
- Merger, 11/05/2010
04-06
State Gazette act
Resignation: Cornelis J. Heiman (director)Appointment: Koenraad Bostoen (director) · Mandate compensation4 facts ▸
- General meeting, 31/03/2008
- Director resignation, Cornelis J. Heiman (director)
- Director appointment, Koenraad Bostoen (director)
- Mandate compensation, Koenraad Bostoen
04-06
State Gazette act
Resignation: Cornelis J Heiman (managing director)Appointment: Koenraad Bostoen (managing director)4 facts ▸
- Board meeting, 08/04/2008
- Director resignation, Cornelis J Heiman (managing director)
- Director appointment, Koenraad Bostoen (managing director)
- Director appointment, Koenraad Bostoen (day-to-day manager)
12-07
State Gazette act
Capital & shares · Statutes amendment · MiscellaneousRegistered-office move4 facts ▸
- General meeting, 08/06/2005
- Registered-office move, 1050 Bruxelles, Boulevard de la Plaine 17
- Statutes amendment
- Statutes amendment
13-07
State Gazette act
Appointments: KPMG Reviseurs d'Entreprises (statutory auditor) and Georges Weissgerber (director)Permanent representative: P. Simons · Resignation: Philippe De Backer (director) · Mandate compensation6 facts ▸
- General meeting, 19/05/2004
- Auditor appointment, KPMG Reviseurs d'Entreprises (statutory auditor)
- Permanent representative, P. Simons
- Director appointment, Georges Weissgerber (director)
- Director resignation, Philippe De Backer (director)
- Mandate compensation, PFIZER
About the unread acts
Of the 54 Belgian State Gazette acts we know for this company, 53 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
Board 3
3 not recently confirmed
Day-to-day management 1
2 not recently confirmed
Not every act has been read: a resignation may be missing here
3 establishment units
3 parcels
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21307E0036/00S004 | Brussels | 11.3 ha | 1 · 2.3 ha | 57.1 m · 5 fl. |
| 71324E0490/00D002 | Flanders | 5.7 ha | 1 · 9,438 m² | 29.9 m · 5 fl. |
| 21445C0281/00S008 | Brussels | 6,782 m² | 1 · 1,582 m² | 37.0 m · 8 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Laurence Einsweiler |
|
| Réginald Decraene |
|
| Kathleen Commers |
|
| Georges Weissgerber |
|
| Koenraad Bostoen |
|
| Laurence Einweller |
|
| Arnaud Conan |
|
| Anne De Backer |
|
| Guy Van den Meersche |
|
| David Lepoittevin |
|
| An Van Gerven |
|
| Karel Van De Sompel |
|
| Didier Vinel |
|
| SCRL Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprise (KPMG) |
|
| Erik BROUWER |
|
| Kristiaan J. WESTELINCK |
|
| Etienne CATTHOOR |
|
| KPMG Réviseurs d'Entreprises |
|
| Cornelis J. Heiman |
|
| Philippe De Backer |
|
Articles of association
Full purpose
La société a pour objet la fabrication et le commerce sous toutes ses formes, en ce y compris la représentation, l'importation et l'exportation de substances et de produits pharmaceutiques, chimiques et biochimiques de toute nature, en ce compris des aliments spéciaux pour animaux, de colorants alimentaires et d'autres produits à usage alimentaire, ainsi que tous produits cosmétiques, de toilette et d'hygiène, sous quelque forme que ce soit, des parfums et autres produits similaires ou intervenant dans la fabrication des produits précités. La Société a également pour objet la fourniture aux professionnels de la santé de conseils et de prestations de services de quelque nature que ce soit dans les domaines pouvant se rattacher directement ou indirectement aux soins de santé en général; Elle peut faire toutes opérations commerciales, industrielles, financières, mobilières ou immobilières se rapportant directement ou indirectement, en tout ou en partie, à son objet, ou qui seraient de nature à en faciliter ou à en développer la réalisation. Elle pourra s'intéresser par voie d'apport, de fusion, de souscription ou de toute autre manière, dans toutes entreprises, associations ou sociétés, dont l'objet serait similaire, analogue, connexe ou simplement utile à la réalisation de tout ou partie de son objet.
Structure & network
Owners and holdings
1 ownerChain of control
- PFIZER INC.US
- Pfizer
Highest known parent: PFIZER INC. (United States). The sources do not say who stands above it.
Owners 1
- PFIZER INC.USparentSourceLEI registerconsolidated
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
2 connected companiesThe connected companies are in the list below.
Ownership & control
2 board mandatesAcquisitions and mergers
4 transactionsCapital and shareholders
- to Pfizer International Markets B.V.
- from Pfizer International Markets Coöperatief UA
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 20-05-2020 Capital increase of 10,750,006.46 EUR · to 39,688,620.47 EUR · 216,166 new shares
- 11-03-2020 Capital stated in the act · 50,000,000 EUR
- 19-03-2019 Capital increase of 10,666,355 EUR · to 39,604,969.01 EUR · 66,895 new shares
- 29-12-2015 Capital reduction of 16,975,840.99 EUR · to 28,938,614.01 EUR
- 30-12-2014 Capital reduction of 18,489,777.79 EUR · to 27,424,677.21 EUR
- 06-11-2013 Capital stated in the act · 149,271 shares
- 27-07-2010 Capital increase of 7,138,000 EUR · to 45,914,455 EUR · 29,399 new shares
Public money · subsidies and aid
European research
1 projectRecognitions · licences · registrations
Food safety, FASFC
1 siteLegal Entity Identifier
Similar companies · same sector, comparable size
Identification & contact
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.